0001209191-19-060277.txt : 20191212
0001209191-19-060277.hdr.sgml : 20191212
20191212182033
ACCESSION NUMBER: 0001209191-19-060277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191210
FILED AS OF DATE: 20191212
DATE AS OF CHANGE: 20191212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Craig A
CENTRAL INDEX KEY: 0001370348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38318
FILM NUMBER: 191282904
MAIL ADDRESS:
STREET 1: C/O PURE BIOSCIENCE
STREET 2: 1725 GILLESPIE WAY
CITY: EL CAJON
STATE: CA
ZIP: 92020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Odonate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001717452
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822493065
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-200-3830
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Odonate Therapeutics, Inc
DATE OF NAME CHANGE: 20171207
FORMER COMPANY:
FORMER CONFORMED NAME: Odonate Therapeutics, LLC
DATE OF NAME CHANGE: 20170919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-10
0
0001717452
Odonate Therapeutics, Inc.
ODT
0001370348
Johnson Craig A
C/O ODONATE THERAPEUTICS, INC.
4747 EXECUTIVE DRIVE, SUITE 510
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
30.51
2019-12-10
4
A
0
12500
0.00
A
2029-12-10
Common Stock
12500
12500
D
The stock options vest and become exercisable as follows: (i) 50% on the date of U.S. Food and Drug Administration ("FDA") approval of tesetaxel; (ii) 25% on the first anniversary of FDA approval of tesetaxel; and (iii) 25% on the second anniversary of FDA approval of tesetaxel. Vesting is subject to the Reporting Person's continued service to the Issuer through each vesting date.
/s/ John Lemkey, as attorney-in-fact for Craig Johnson
2019-12-12